AAPL345.97+2.06 (+0.60%) ▲|ABBV286.81+0.07 (+0.02%) ▲|ABT104.13-0.76 (-0.72%) ▼|ACN236.65-10.58 (-4.28%) ▼|ADBE249.57-9.05 (-3.50%) ▼|AMAT395.82+8.23 (+2.12%) ▲|AMD559.85+28.57 (+5.38%) ▲|AMGN446.95+2.32 (+0.52%) ▲|AMT183.14-5.15 (-2.73%) ▼|AMZN254.04+4.95 (+1.99%) ▲|AVGO341.92+12.75 (+3.87%) ▲|AXP313.40-1.66 (-0.53%) ▼|BA170.20-18.11 (-9.62%) ▼|BAC50.71+0.19 (+0.37%) ▲|BKNG150.71-2.44 (-1.59%) ▼|BLK1,131.37+3.71 (+0.33%) ▲|BMY61.29-0.32 (-0.52%) ▼|BNY147.72+0.54 (+0.37%) ▲|BRK-B545.02-3.54 (-0.65%) ▼|C122.68+1.64 (+1.35%) ▲|CAT713.23+21.10 (+3.05%) ▲|CL92.06-1.05 (-1.12%) ▼|CMCSA21.81-0.25 (-1.11%) ▼|COF204.16+1.81 (+0.89%) ▲|COP148.20-3.18 (-2.10%) ▼|COST992.04-13.12 (-1.31%) ▼|CRM241.95-5.66 (-2.29%) ▼|CSCO111.53+1.29 (+1.17%) ▲|CVS91.35-1.18 (-1.28%) ▼|CVX229.08-2.93 (-1.26%) ▼|DE639.64-1.61 (-0.25%) ▼|DHR232.12-0.85 (-0.36%) ▼|DIS109.86-0.54 (-0.49%) ▼|DUK124.10-0.34 (-0.27%) ▼|EMR165.60+3.90 (+2.41%) ▲|FDX307.15+6.57 (+2.19%) ▲|GD355.10-1.94 (-0.54%) ▼|GE298.08+9.65 (+3.35%) ▲|GEV887.49+32.87 (+3.85%) ▲|GILD157.94-0.75 (-0.47%) ▼|GM80.55+4.24 (+5.56%) ▲|GOOG318.30+4.11 (+1.31%) ▲|GOOGL321.90+5.10 (+1.61%) ▲|GS911.91+18.63 (+2.09%) ▲|HD318.79-0.59 (-0.18%) ▼|HON217.61-1.67 (-0.76%) ▼|IBM250.38-3.07 (-1.21%) ▼|INTC93.38+2.91 (+3.21%) ▲|INTU326.19-13.70 (-4.03%) ▼|ISRG446.61-5.02 (-1.11%) ▼|JNJ268.49+2.19 (+0.82%) ▲|JPM336.16+2.12 (+0.63%) ▲|KO91.65-1.05 (-1.13%) ▼|LIN507.11-0.45 (-0.09%) ▼|LLY1,281.29+2.15 (+0.17%) ▲|LMT623.94-11.26 (-1.77%) ▼|LOW197.99-0.23 (-0.12%) ▼|LRCX240.52+3.02 (+1.27%) ▲|MA607.95-5.55 (-0.90%) ▼|MCD249.67-1.17 (-0.46%) ▼|MDLZ62.05-0.93 (-1.47%) ▼|MDT94.36-0.43 (-0.45%) ▼|META622.57-8.00 (-1.27%) ▼|MMM171.83-0.96 (-0.56%) ▼|MO73.35-0.28 (-0.37%) ▼|MRK142.18+1.57 (+1.12%) ▲|MS187.39+3.90 (+2.13%) ▲|MSFT531.20-1.40 (-0.26%) ▼|MU931.47+27.77 (+3.07%) ▲|NEE82.19+0.15 (+0.18%) ▲|NFLX62.71-1.20 (-1.87%) ▼|NKE37.44-0.48 (-1.25%) ▼|NOW155.64-2.54 (-1.61%) ▼|NVDA217.78+1.78 (+0.82%) ▲|ORCL131.60+5.54 (+4.39%) ▲|PEP132.66-2.80 (-2.07%) ▼|PFE29.75-0.05 (-0.15%) ▼|PG158.98-0.94 (-0.59%) ▼|PLTR199.44+0.60 (+0.30%) ▲|PM203.18+1.31 (+0.65%) ▲|QCOM181.79+2.19 (+1.22%) ▲|RTX195.29-2.20 (-1.11%) ▼|SBUX102.52-0.18 (-0.17%) ▼|SCHW89.62-0.11 (-0.12%) ▼|SO92.14-0.44 (-0.47%) ▼|SPG211.92-0.77 (-0.36%) ▼|T20.98+0.13 (+0.60%) ▲|TMO698.34+13.45 (+1.96%) ▲|TMUS147.04+0.11 (+0.07%) ▲|TSLA406.03+14.41 (+3.68%) ▲|TXN307.36+9.24 (+3.10%) ▲|UBER65.90-0.24 (-0.36%) ▼|UNH409.45-1.25 (-0.30%) ▼|UNP299.26+2.29 (+0.77%) ▲|UPS105.72+5.40 (+5.38%) ▲|USB59.77+0.07 (+0.11%) ▲|V398.62-5.54 (-1.37%) ▼|VZ43.79+0.69 (+1.59%) ▲|WFC82.76+0.11 (+0.13%) ▲|WMT118.96-1.34 (-1.11%) ▼|XOM180.97-3.57 (-1.93%) ▼|AAPL345.97+2.06 (+0.60%) ▲|ABBV286.81+0.07 (+0.02%) ▲|ABT104.13-0.76 (-0.72%) ▼|ACN236.65-10.58 (-4.28%) ▼|ADBE249.57-9.05 (-3.50%) ▼|AMAT395.82+8.23 (+2.12%) ▲|AMD559.85+28.57 (+5.38%) ▲|AMGN446.95+2.32 (+0.52%) ▲|AMT183.14-5.15 (-2.73%) ▼|AMZN254.04+4.95 (+1.99%) ▲|AVGO341.92+12.75 (+3.87%) ▲|AXP313.40-1.66 (-0.53%) ▼|BA170.20-18.11 (-9.62%) ▼|BAC50.71+0.19 (+0.37%) ▲|BKNG150.71-2.44 (-1.59%) ▼|BLK1,131.37+3.71 (+0.33%) ▲|BMY61.29-0.32 (-0.52%) ▼|BNY147.72+0.54 (+0.37%) ▲|BRK-B545.02-3.54 (-0.65%) ▼|C122.68+1.64 (+1.35%) ▲|CAT713.23+21.10 (+3.05%) ▲|CL92.06-1.05 (-1.12%) ▼|CMCSA21.81-0.25 (-1.11%) ▼|COF204.16+1.81 (+0.89%) ▲|COP148.20-3.18 (-2.10%) ▼|COST992.04-13.12 (-1.31%) ▼|CRM241.95-5.66 (-2.29%) ▼|CSCO111.53+1.29 (+1.17%) ▲|CVS91.35-1.18 (-1.28%) ▼|CVX229.08-2.93 (-1.26%) ▼|DE639.64-1.61 (-0.25%) ▼|DHR232.12-0.85 (-0.36%) ▼|DIS109.86-0.54 (-0.49%) ▼|DUK124.10-0.34 (-0.27%) ▼|EMR165.60+3.90 (+2.41%) ▲|FDX307.15+6.57 (+2.19%) ▲|GD355.10-1.94 (-0.54%) ▼|GE298.08+9.65 (+3.35%) ▲|GEV887.49+32.87 (+3.85%) ▲|GILD157.94-0.75 (-0.47%) ▼|GM80.55+4.24 (+5.56%) ▲|GOOG318.30+4.11 (+1.31%) ▲|GOOGL321.90+5.10 (+1.61%) ▲|GS911.91+18.63 (+2.09%) ▲|HD318.79-0.59 (-0.18%) ▼|HON217.61-1.67 (-0.76%) ▼|IBM250.38-3.07 (-1.21%) ▼|INTC93.38+2.91 (+3.21%) ▲|INTU326.19-13.70 (-4.03%) ▼|ISRG446.61-5.02 (-1.11%) ▼|JNJ268.49+2.19 (+0.82%) ▲|JPM336.16+2.12 (+0.63%) ▲|KO91.65-1.05 (-1.13%) ▼|LIN507.11-0.45 (-0.09%) ▼|LLY1,281.29+2.15 (+0.17%) ▲|LMT623.94-11.26 (-1.77%) ▼|LOW197.99-0.23 (-0.12%) ▼|LRCX240.52+3.02 (+1.27%) ▲|MA607.95-5.55 (-0.90%) ▼|MCD249.67-1.17 (-0.46%) ▼|MDLZ62.05-0.93 (-1.47%) ▼|MDT94.36-0.43 (-0.45%) ▼|META622.57-8.00 (-1.27%) ▼|MMM171.83-0.96 (-0.56%) ▼|MO73.35-0.28 (-0.37%) ▼|MRK142.18+1.57 (+1.12%) ▲|MS187.39+3.90 (+2.13%) ▲|MSFT531.20-1.40 (-0.26%) ▼|MU931.47+27.77 (+3.07%) ▲|NEE82.19+0.15 (+0.18%) ▲|NFLX62.71-1.20 (-1.87%) ▼|NKE37.44-0.48 (-1.25%) ▼|NOW155.64-2.54 (-1.61%) ▼|NVDA217.78+1.78 (+0.82%) ▲|ORCL131.60+5.54 (+4.39%) ▲|PEP132.66-2.80 (-2.07%) ▼|PFE29.75-0.05 (-0.15%) ▼|PG158.98-0.94 (-0.59%) ▼|PLTR199.44+0.60 (+0.30%) ▲|PM203.18+1.31 (+0.65%) ▲|QCOM181.79+2.19 (+1.22%) ▲|RTX195.29-2.20 (-1.11%) ▼|SBUX102.52-0.18 (-0.17%) ▼|SCHW89.62-0.11 (-0.12%) ▼|SO92.14-0.44 (-0.47%) ▼|SPG211.92-0.77 (-0.36%) ▼|T20.98+0.13 (+0.60%) ▲|TMO698.34+13.45 (+1.96%) ▲|TMUS147.04+0.11 (+0.07%) ▲|TSLA406.03+14.41 (+3.68%) ▲|TXN307.36+9.24 (+3.10%) ▲|UBER65.90-0.24 (-0.36%) ▼|UNH409.45-1.25 (-0.30%) ▼|UNP299.26+2.29 (+0.77%) ▲|UPS105.72+5.40 (+5.38%) ▲|USB59.77+0.07 (+0.11%) ▲|V398.62-5.54 (-1.37%) ▼|VZ43.79+0.69 (+1.59%) ▲|WFC82.76+0.11 (+0.13%) ▲|WMT118.96-1.34 (-1.11%) ▼|XOM180.97-3.57 (-1.93%) ▼|
14.6 C
New York
Tuesday, October 27, 2026

Tag: inhibitors

newsFORsourcecompanycontentinformation1releasesmarket

Anti-CCR8 Antibodies Market to Witness Remarkable Growth Trajectory During the Forecast Period (2025-2040) Across 7MM | DelveInsight

The anti-CCR8 antibodies market holds potential in addressing unmet needs across inflammatory and cancerous diseases. The anti-CCR8 inhibitor market is expected to witness substantial...

Global Cancer Immunotherapy Market Projected to Reach $247 Billion by 2029, Driven by 11.4% CAGR

"Harnessing the Power of the Immune System: How Cancer Immunotherapy and Oncolytic Virology Are Reshaping the Future of Oncology in a Digitally Driven Era" BOSTON,...

Everest Medicines to Host Virtual Nephrology-Focused KOL Event on June 30, 2025

SHANGHAI, June 26, 2025 (GLOBE NEWSWIRE) -- Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it will host a virtual nephrology-focused key opinion leader (KOL) event on Monday, June 30, 2025 at 8:00 AM ET. For English speakers, please click here to register. For individuals preferring instant Chinese translation, please click here.

STORM Therapeutics Appoints Veteran Cancer Drug Developer Dr. Eric Martin as Chief Development Officer

CAMBRIDGE, England, June 26, 2025 /PRNewswire/ -- STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today...

BioCity’s ETA-Selective Antagonist SC0062 Granted Breakthrough Therapy Designation in China for Diabetic Kidney Disease with Albuminuria

Second BTD Recognition Highlights Compound's Potential as Next-Generation Broad-Spectrum Renal TherapySHANGHAI, June 25, 2025 /PRNewswire/ -- BioCity Biopharma ("BioCity") announced today that the Center for...

Rakovina Therapeutics Announces Results from 2025 Annual General Meeting

VANCOUVER, British Columbia, June 25, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (“Rakovina” or the “Company”), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery is pleased to announce the results of voting at its 2025 annual general meeting of shareholders held on June 25, 2025, in Vancouver, British Columbia (the “Meeting”).

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsInhibitors

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers